Breast cancer [NEW TOPIC PAGE]

Main|Search|PHGKB




Last Posted: May 03, 2018

---

• Breast Cancer Prevention (PDQ®)–Patient Version  
• A randomized phase II trial of trastuzumab plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and taxanes: WJOG6110B/ELTOP.  
  Takano Toshimi, et al. Breast (Edinburgh, Scotland) 2018 4 67-75
• Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.  
  Pande Mala, et al. PloS one 2018 0 (4) e0196245
• Detection of a 4-bp Insertion/deletion Polymorphism within the Promoter of EGLN2 Using Mismatch PCR-RFLP and Its Association with Susceptibility to Breast Cancer  
  Hashemi Mohammad, et al. Asian Pacific journal of cancer prevention : APJCP 2018 4 (4) 923-926
• Association of ATM and BMI-1 genetic variation with breast cancer risk in Han Chinese.  
  Yue Li-Ling, et al. Journal of cellular and molecular medicine 2018 4
• The BRCA1 and BRCA2 Genes in Early-Onset Breast Cancer Patients.  
  Saleem Mohamed, et al. Advances in experimental medicine and biology 2018 4

more